Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat)

Journal of Heart and Lung Transplantation

Volumn 24, Issue 6, 2005, Pages 708-713

  Koch, Achim ^a   Daniel, Volker ^a   Dengler, Thomas J ^a   Schnabel, Philipp Albert ^a   Hagl, Siegfried ^a   Sack, Falk Udo ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMIPENEM; METHYLPREDNISOLONE; MISOPROSTOL; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HELPER CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; INTRAOPERATIVE PERIOD; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; SEROCONVERSION; STERNUM; SUPPRESSOR CELL; SURVIVAL RATE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTILYMPHOCYTE SERUM; BONE DISEASES, INFECTIOUS; CYTOMEGALOVIRUS INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STERNUM; T-LYMPHOCYTES;

EID: 20444398138     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.04.014     Document Type: Article

References (21)

1. G.M. Abouna, I.H. Al-Abdullah, D. Kelly-Sullivan Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T-cell monitoring Transplantation 59 1995 1564 1568
2. M. Beaufigeau, D. Dumesnil, M. Carrier, M. White, G.B. Pelletier Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute Transplant Proc 29 suppl 1997 10 12
3. S.F. Bolling, M.C. Stirling, P. Miska, G.M. Deeb Comparison of polyclonal antibody sera for early prophylaxis following heart transplantation J Surg Res 47 1989 292 296
4. Monitoring of ATG therapy by flow cytometry and lymphocyte counts in renal transplantation Transplant Proc 28 1996 2817 2818
5. J.A. Carey, W.H. Frist Use of polyclonal antilymphocytic preparations for prophylaxis in heart transplantation J Heart Lung Transplant 9 1990 297 300
6. M. Carrier, M. White, L.P. Perrault A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation J Heart Lung Transplant 18 1999 1218 1223
7. B. Charpentier, C. Hiesse, S. Marchand Induction therapies with polyclonal antithymocyte globulins or monoclonal antibodies Transplant Proc 32 2000 367
8. N.C. Chien, F.L. Lin, N.K. Chou Rabbit antihymocyte globulin induction immunosuppression in heart transplantation Transplant Proc 32 2000 2380 2382
9. K.R. Clark, J.L.R. Forsythe, B.K. Shenton, T.W.J. Lennard, G. Pround, R.M.R. Taylor Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection Transplant Int 6 1993 18 21
10. J.G. Copeland, T.B. Icenogle, R.J. Williams Rabbit antithymocyte globulin J Thorac Cardiovasc Surg 99 1990 852 860
11. D. Ducloux, P.L. Carron, G. Motte Lymphocyte subsets and assessment of cancer risk in renal transplant recipients Transplant Int 15 2002 393 396
12. S.C.D. Grant, W.R. Lamb, N. Yonan, I.V. Hutchinson, P.E.C. Brenchley Antithymocyte globulin preparations after heart transplantation Transplantation 60 1995 684 689
13. A.M. Kransinskas, D. Kreisel, M.A. Acker CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation Transplantation 73 2002 1339 1341
14. K. Krogsgaard, S. Boesgaard, J. Aldershvile, H. Arendrup, S.A. Mortensen, G. Petterson Cytomegalovirus infection rate among heart transplant patiens in relation to the potency of antithymocyte immunoglobulin induction therapy Transplant Proc 26 1994 1718
15. J. Lavee, D. Bar-Zohar, Y. Har-Zahav Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients 6-year experience at the sheba medical center Transplant Proc 32 2000 737 739
16. L.K. Lebeck, L. Chang, C. Lopez-McCormack, R. Chinnock, M. Boucek Polyclonal antithymocyte serum immune prophylaxis and rejection therapy in pediatric heart transplantion patients J Heart Lung Transplant 12 suppl 1993 S286 S292
17. B. Reckzeh, S.O. Grebe, I. Rhiele, A. Neubauer, T.F. Müller Monitoring of ATG therapy by flow cytometry comparisons of one single-platform and two different dual-platform methods Transplant Proc 33 2001 2234 2236
18. B. Schnetzler, P. Leger, A. Völp, R. Dorent, A. Pavie, I. Gandjbakhch A prospective randomised controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients Transplant Int 15 2002 317 325
19. F.M. Wagner, S.M. Tugtekin, K. Matschke, U. Platzbecker, V. Gulielmos, S. Schüler Flow cytometric ATG induction therapy and noninvasive monitoring of graft rejection a new treatment concept after heart surgery Langenbecks Arch Chir XX suppl II 1998 1566 1567
20. T. Wahlers Cytolytic induction therapy in heart and lung transplantation the protagonist opinion Transplant Proc 30 1998 1100 1103
21. A.O. Zuckermann, M. Grimm, M. Czerny Improved long-term results with thymoglobuline induction therapy after cardiac transplantation a comparison of two different rabbit-antithymocyte globulines Transplantation 69 2000 1890 1898